• Explore /
  • Poster
  • / A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.

A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.

Abstract Poster

Authors

null

Andrew Barbour

University of Queensland, Brisbane, Australia

Andrew Barbour , Nicholas O'Rourke , Jaswinder S. Samra , Koroush S Haghighi , James Kench , Jenna Mitchell , Nick Pavlakis , Matthew E. Burge , Jonathan Fawcett , Sivikumar Gananadha , Marion Harris , Morteza Aghmesheh , Yu Jo Chua , Warren Lance Joubert , Matthew MK Chan , Manju Dashini Chandrasegaram , Sonia Yip , John Simes , Val Gebski , David Goldstein

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

12611000848909

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr 387)

DOI

10.1200/jco.2015.33.3_suppl.387

Abstract #

387

Poster Bd #

D6

Abstract Disclosures

Similar Posters

First Author: Sarah E. Hoffe

First Author: Thomas Jens Ettrich

First Author: Lars M. Wagner

First Author: Manisha Palta